You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 38 No. 11, November 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Plasma MHPG in Rapid Cyclers and Healthy Twins

David C. Jimerson, MD; John I. Nurnberger, Jr, MD; Robert M. Post, MD; Elliot S. Gershon, MD; Irwin J. Kopin, MD

Arch Gen Psychiatry. 1981;38(11):1287-1290.


Abstract

• We measured plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) in 13 pairs of healthy drug-free monozygotic twins. High concordance for both free and conjugated MHPG suggests that plasma levels of the metabolite may reflect a heritable biological trait. In two drug-free rapidly cycling patients studied longitudinally, plasma MHPG levels reflected alterations in psychiatric state; they were significantly higher during mania than during depression. Although largely reflecting peripheral sources, plasma MHPG level as a global index of noradrenergic function may complement urinary MHPG excretion as a probe for diagnostic subgroups or pharmacologic responsiveness in psychiatric research.



Author Affiliations

From the Section on Psychogenetics (Drs Jimerson, Nurnberger, and Gershon) and the Section on Psychobiology (Dr Post), Biological Psychiatry Branch, and the Laboratory of Clinical Science (Dr Kopin), National Institute of Mental Health, Bethesda, Md. Dr Jimerson is now with the Section on Medicine, Laboratory of Clinical Science.


Footnotes

Accepted for publication June 12, 1981.

Reprint requests to Section on Medicine, Laboratory of Clinical Science, Bldg 10, Room 2D46, National Institute of Mental Health, 9000 Rockville Pike, Bethesda, MD 20205 (Dr Jimerson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bipolar Disorder and Epilepsy: A Bidirectional Relation? Neurobiological Underpinnings, Current Hypotheses, and Future Research Directions
Mazza et al.
Neuroscientist 2007;13:392-404.
ABSTRACT  

The Diurnal Variation in Plasma Homovanillic Acid Level Persists but the Variation in 3-Methoxy-4-hydroxyphenylglycol Level Is Abolished Under Constant Conditions
Sack et al.
Arch Gen Psychiatry 1988;45:162-166.
ABSTRACT  

Afternoon Continuous Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol and Age: Distinctive Biologic Subgroups of Endogenous Depression?
Halbreich et al.
Arch Gen Psychiatry 1987;44:804-812.
ABSTRACT  

Urinary 3-Methoxy-4-Hydroxyphenylglycol and Major Affective Disorders: A Replication and New Findings
Muscettola et al.
Arch Gen Psychiatry 1984;41:337-342.
ABSTRACT  

Increased Plasma MHPG in Dexamethasone-Resistant Depressed Patients
Jimerson et al.
Arch Gen Psychiatry 1983;40:173-176.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.